ClinicalTrials.gov
public full text
Public Domain
Iranian Intensive Care Unit (ICU) Glutamine Study
This is a double-blinded placebo-controlled block randomized study in intensive care patients comparing enteral glutamine supplementation to placebo. The hypothesis is an improvement of clinical and paraclinical outcomes. The primary endpoint is Infection Probability Score (IPS) and Systemic Inflammatory Response Syndrome (SIRS). Anthropometric measures and serum inflammatory mediators will be compared.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Antibiograms of Intensive Care Units at an Egyptian Tertiary Care Hospital#217069
- Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients#1008294
- French and EuRopean Outcome Registry in Intensive Care Unit#1152831
- Impact of Interventions on Admission SOFA Score on Clinical Outcomes of Critically Ill Patients#869961
- Comparative Study for the Validity of Various Severity Scoring System#979556
Record · ID 1088816
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive